Stock Price
244.80
Daily Change
-6.60 -2.63%
Monthly
-38.35%
Yearly
-61.70%
Q1 Forecast
285.47

Novo Nordisk reported DKK37.3B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Bausch Health Companies USD 986M 74M Sep/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Novartis USD 5.88B 290M Sep/2025
Novo Nordisk DKK 37.3B 5.86B Dec/2025
Novo Nordisk DKK 31.44B 6.84B Sep/2025
Pacira USD 49.36M 4.96M Sep/2025
Sanofi EUR 4.84B 2.95B Sep/2025
Supernus Pharmaceuticals USD 41.9M 432K Sep/2025